Pablo Cironi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pablo cironi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pablo Cironi Today - Breaking & Trending Today

Minoryx raises EUR 51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

Minoryx Therapeutics, a Phase 3 stage biotech company focused on the development of treatments for orphan central nervous system (CNS) disorders, today announces it has closed a EUR 51 million financing, including Series C equity financing and complementary bank debt. Minoryx will use the funding to finance the . ....

Comunidad Autonoma De Cataluna , Pablo Cironi , Marc Martinell , Columbus Venture Partners , Caixa Capital Risc , Ysios Capital , Caixa Capital , Belgian Public , Managing Director , Columbus Venture , Life Science Investment Funds ,

Sanifit Seals Booming Acquisition Year for Spanish Life Sciences

The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high point for the life sciences sector in Spain, which has seen a burst of acquisitions this year. ....

United Kingdom , Comunidad Autonoma De Cataluna , Palo Biopharma , Pablo Cironi , Joan Perell , Vifor Pharma , Life Sciences Investments At Caixa Capital Risc , Life Sciences Investments , Caixa Capital Risc , Managing Partner , Ysios Capital , Origo Biopharma , Agomab Therapeutics , Biotech Foods , Mosaic Biomedical ,

Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M

Barcelona, Spain, November 23, 2021 – Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its portfolio company Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company that aims to become an industry leader in iron deficiency, nephrology and cardio-renal the. ....

Comunidad Autonoma De Cataluna , Pablo Cironi , Joan Perell , Vifor Pharma , Boehringer Ingelheim , Malta Life Sciences , Centre For The Development Of Industrial Technology , Swiss Stock Exchange , Swiss Exchange , University Of The Balearic , Vifor Pharma Group , Fresenius Medical Care , Caixa Capital Risc , Sanifit Therapeutics , Balearic Islands , Calcific Uremic Arteriolopathy , Peripheral Artery Disease , Capital Risc , Caixa Capital , Caixa Capital Risk , Criteria Bio Ventures , Northern Biologics , Foreign Direct Investment , Uremic Arteriolopathy , End Stage Renal Disease , Cardiovascular Calcification ,